Los Contratos por diferencia («CFD») son instrumentos complejos que comportan un riesgo elevado de pérdidas rápidas debido al apalancamiento. El 74% de las cuentas de inversores particulares pierde dinero al operar CFD con este proveedor. Debe considerar si comprende el funcionamiento de los CFD y si puede permitirse asumir un riesgo elevado de perder su dinero.

Close

Opere Bristol Myers BMY

Vender
 Comprar

BristolMyers gráfico en tiempo real

5m 15m 30m 1h 4h 1d 1w

Fundamentales del instrumento

Weekly Search
Weekly
Daily
Fecha Cerrar Cambio Cambio del % Apertura Alto Bajo

Últimas noticias

Closing 2024
2024 Dec 26, 17:00

Adelanto semanal: Cierre de 2024 y primeros datos económicos de 2025

Índices Forex
UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Adelanto semanal: Última semana completa de 2024 en los mercados financieros

Índices Forex
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

Adelanto semanal: Tasas en EE. UU. e inflación en Europa determinarán el curso del mercado

Forex Índices
Dyogenes Diniz 2024 Dec 05, 16:00

Adelanto semanal: La inflación y las tasas de interés sacudirán los mercados esta semana

Forex Índices
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Adelanto semanal:  El empleo en EE. UU. marcará probablemente el sentimiento de mercado esta semana.

Forex Índices
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Adelanto semanal:  Inflación de la Eurozona podría confirmar el recorte del BCE en diciembre

Forex Índices
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Adelanto semanal: El rally tecnológico dependerá de los resultados de Nvidia

Forex Índices
Markets.com Support Team 2024 Nov 07, 16:00

Adelanto semanal: «Trump Trade», datos de inflación, resultados de Disney

Forex Índices

Información

Spread

0.31

Spread (%)

0.6164 %

Apalancamiento

1:5

Interés a un día (Compra)

-0.0597 %

Interés a un día (Venta)

-0.0292 %

Divisa

USD

Horarios de los mercados

Markets closed

Viernes

13:31 - 19:59

Lunes

13:31-19:59

Martes

13:31-19:59

Miércoles

13:31-19:59

Jueves

13:31-19:59

Análisis y estadísticas

Apertura

---

Cierre anterior

---

Máximo/mínimo de 52 semanas

--- – ---

Capitalización de mercado

103182671872

Acciones en circulación

2034759936

Fecha de ganancias (próxima)

2001-08-07

Rentabilidad por div. 

2025-05-01

Fecha exdividendo

2025-04-04

Tasa de dividendo anual anticipado

2.48

Rendimiento de dividendo anual anticipado

0.0489

GPA

-4.41

Conoce más sobre este instrumento

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

Instrumentos relacionados

Activo
Vender
Comprar
Cambio del %

Opere ahora

Opere ahora

Opere ahora

Opere ahora
Instrumentos relacionados
Trustpilot
RequestMessages58TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version18.11msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
18.33ms
peak_memory
6MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktv4_ip_override=es-es; mktloc=eyJpdiI6IlNjeHQxQlhJdE1kSUN5T1Yyc1hXdXc9PSIsInZhbHVlIjoiRzUySEQ3aCtSR0QwNHNEK21adlpmV3k2eGNPL1VNMElYdVF3NTBGU1JzcnZ5U0FpRy82RUJZbCt5RUdZNmF0NiIsIm1hYyI6IjQ5OGRjODFkMGE5ODI0MmFmYzE4NjE4OGJlY2M0MTUzMDYwNGM3ZWMyNDgwOTc5Mzk4YjY0MDU0ODQ0OGM4MjYiLCJ0YWciOiIifQ%3D%3D; intent_group=%252Fes-es%252Finstrument%252Fbristolmyers%252F; intent_instrument=bristolmyers; XSRF-TOKEN=eyJpdiI6IlROT0pFQkJad0ZTSk0zM0NqckhTNVE9PSIsInZhbHVlIjoiWmhvSkdSdThnS3VwWm82UlJDdUUrNzdzS045c0xjZ2RPT3ZELzdOc3ZDaHYvb0F3MDlSVTFLdnZxSVo1MEhVdVA0dFVkcTc2WERuTG5jTGpOZVg0Y2wyWU10ZmNvNVpQdHBIRWluZTIwazMvc2FUS2dzbE8xaE1TYVdidTg0QnAiLCJtYWMiOiJjYzdkNWJiNzhiOTBmZDQ1MmQ3YWFjZjNkNTI4MTRjNDVlYmJhOWVhNDZmODY2YjdhOGRkYWE3YmQwMTY3NDY3IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6ImVzZDZvUVRhcXpzeWFlMnIzVi9KUFE9PSIsInZhbHVlIjoiOU81SDVkWjdBRlIxa01kMk9vUHRQMG83WmpuRjgwRDZWM2hZRVVsUEhaVlE1alk2dVpESEVUUDNFNDNicWUwU1Y3U2s0NmZsRndzazR2eUlXZ1g3cWdHTlo3QXl0TExaNEpSdnhMczVabU1LQkRwUU5OUjFjMStpeEFZamdsNVoiLCJtYWMiOiJmNjc3Mzc0MWM4NDY0OTlmMWI4ZDI3OTFjM2M3ODQ1YzI3Y2NkYWQxNWZkODVmNzRlYjg2MThkMzg4ODAwYjFjIiwidGFnIjoiIn0%3D; firstURL=https://web-qa.staging.markets.com/es-es/instrument/prosiebensat/; lastURL=https://web-qa.staging.markets.com/es-es/instrument/prosiebensat/ ◀mktv4_ip_override=es-es; mktloc=eyJpdiI6IlNjeHQxQlhJdE1kSUN5T1Yyc1hXdXc9PSIsInZhbHVlIjoiRzUySEQ3aCtSR0QwNHNEK21adlpmV3k2eGNPL1VNMElYdVF3NTBGU1JzcnZ5U0FpRy82RUJZ ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:8 [▼
  "mktv4_ip_override" => null
  "mktloc" => "us,us"
  "intent_group" => null
  "intent_instrument" => null
  "XSRF-TOKEN" => "Y5Ggs3NMgx4R9ZQbiif4tE4jLqOhhTQ8vDj4C1QK"
  "laravel_session" => "JjYp0LwUy0F3YUQCIpY81gvs4GvvFjcNMMBZLrdM"
  "firstURL" => null
  "lastURL" => null
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Mon, 14 Apr 2025 16:18:59 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "Y5Ggs3NMgx4R9ZQbiif4tE4jLqOhhTQ8vDj4C1QK"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/csrf"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (9.04ms)time
    • Application (9.07ms)time
    • Routing (490μs)
    • 1 x Application (50.06%)
      9.07ms
      1 x Booting (49.88%)
      9.04ms
      1 x Routing (2.7%)
      490μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              Y5Ggs3NMgx4R9ZQbiif4tE4jLqOhhTQ8vDj4C1QK
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/csrf" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-14 16:18:56GET/es-es/instrument/bristolmyers/5867
              #22025-04-14 16:18:58GET/csrf/ (ajax)
              #32025-04-14 16:18:59GET/params/ (ajax)